During this session we will 1) describe the science and measurement of implicit bias, 2) demonstrate the specific physician behaviors that have been found to be associated with implicit bias, and 3) provide training on a patient-driven patient-centered communication as a way to mitigate the influence of implicit bias. 

 Learning Objectives:  

• To understand the science and measurement of implicit bias research 
• To understand how implicit bias can negatively influence human behavior with a focus on decision making and communication behavior with patients. 
• To articulate evidence-based strategies to mitigate the influence of implicit bias on decision making and behavior.

*This session meets the state mandate for implicit bias training and includes one hour of training.*

Guest Speaker:

Lauren Hamel, PhD, is an associate professor and scientific member of the Population Studies and Disparities Research Program at the Karmanos Cancer Institute and the Wayne State University School of Medicine. Dr. Hamel is an expert in patient-physician communication, cancer treatment disparities, and in building and testing interventions to improve patient physician communication. 

Speakers: Have no commercial/financial relationships

Planning Committee Members: Basim Dubaybo, M.D. (Activity Director), Teena Chopra, M.D., Claire Pearson, M.D., Kate Laimbeer and Kailah Weatherspoon have no commercial/financial relationships.

Target Audience: Wayne State University School of Medicine faculty, staff, medical students, fellow and residents

The Wayne State University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The Wayne State University School of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit (s) TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure of Conflicts of Interest: This program is not related to specific diseases or conditions but rather deal exclusively with non-clinical medical education. Therefore, there are no potential conflicts of interest with ineligible companies as defined by ACCME and there is no need to identify, disclose or mitigate commercial conflicts of interest.